Table 1
Primer sequences used for selected cell death-related genes
| Gene | Reference sequence No. (FASTA format) | Primers |
|---|---|---|
| BECN1 | NM_003766.5 | Forward: CTCCCGAGGTGAAGAGCATC Reverse: GGGGGATGAATCTGCGAGAG |
| SQSTM1 | NM_003900.5 | Forward: CCGTGAAGGCCTACCTTCTG Reverse: TCCTCGTCACTGGAAAAGGC |
| BCL-2 | NM_000633.3 | Forward: GGGGTCATGTGTGTGGAGAG Reverse: GAAATCAAACAGAGGCCGCA |
| DRAM1 | NM_018370.3 | Forward: TTGGTGCAGCCACGATGTAT Reverse: ACACCACAGACAAAGGCCAA |
Table 2
Changes in relative BCL-2 gene expression after GR-M and PBM cell treatment with halogenated boroxine compared to negative control
Table 3
Changes in relative BECN1 gene expression after GR-M and PBM cell treatment with halogenated boroxine compared to negative control
Table 4
Changes in relative DRAM1 gene expression after GR-M and PBM cell treatment with halogenated boroxine compared to negative control
Table 5
Changes in relative SQSTM1 gene expression after GR-M and PBM cell treatment with halogenated boroxine compared to negative control
Figure 1
Growth inhibition of GR-M and PBM cells treated with different concentrations of halogenated boroxine; *p<0.05